Literature DB >> 1775863

Prognosis of enterococcal endocarditis.

B Almirante, M P Tornos, M Gurgui, M Pujol, J M Miró.   

Abstract

Entities:  

Mesh：

Year:  1991        PMID： 1775863     DOI： 10.1093/clinids/13.6.1248

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN： 0162-0886


× No keyword cloud information.
  6 in total

1.  Pathogenic Mechanisms of Enterococcal Endocarditis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-08       Impact factor: 3.725

2.  Comparative study of bacteremias caused by Enterococcus spp. with and without high-level resistance to gentamicin. The Grupo Andaluz para el estudio de las Enfermedades Infecciosas.

Authors:  F J Caballero-Granado; J M Cisneros; R Luque; M Torres-Tortosa; F Gamboa; F Díez; J L Villanueva; R Pérez-Cano; J Pasquau; D Merino; A Menchero; D Mora; M A López-Ruz; A Vergara
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

3.  Cloning of an Enterococcus faecalis endocarditis antigen: homology with adhesins from some oral streptococci.

Authors:  A M Lowe; P A Lambert; A W Smith
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

4.  Antibodies to a surface-exposed, N-terminal domain of aggregation substance are not protective in the rabbit model of Enterococcus faecalis infective endocarditis.

Authors:  J K McCormick; H Hirt; C M Waters; T J Tripp; G M Dunny; P M Schlievert
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

5.  Enterococcal prosthetic valve infective endocarditis: report of 45 episodes from the International Collaboration on Endocarditis-merged database.

Authors:  D J Anderson; L Olaison; J R McDonald; J M Miro; B Hoen; C Selton-Suty; T Doco-Lecompte; E Abrutyn; G Habib; S Eykyn; P A Pappas; V G Fowler; D J Sexton; M Almela; G R Corey; C H Cabell
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-10       Impact factor: 3.267

6.  Efficacy of ampicillin plus ceftriaxone in treatment of experimental endocarditis due to Enterococcus faecalis strains highly resistant to aminoglycosides.

Authors:  J Gavaldà; C Torres; C Tenorio; P López; M Zaragoza; J A Capdevila; B Almirante; F Ruiz; N Borrell; X Gomis; C Pigrau; F Baquero; A Pahissa
Journal:  Antimicrob Agents Chemother       Date:  1999-03       Impact factor: 5.191
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.